Evidence map›Paper›PMID 38266043›Full record

ArticlePLoS medicine2024

Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.

Laura Panagi, Simon R White, Snehal M Pinto Pereira, Manjula D Nugawela, Isobel Heyman, Kishan Sharma, Terence Stephenson, Trudie Chalder, Natalia K Rojas, Emma Dalrymple and 6 more

Abstract read
In one paragraph

Article in PLoS medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laura PanagiDepartment of Psychiatry, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-6752-726X
Simon R WhiteDepartment of Psychiatry, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-8642-7037
Snehal M Pinto PereiraDivision of Surgery & Interventional Science, Faculty of Medical Sciences, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-0876-8757
Manjula D NugawelaUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Isobel HeymanUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-7358-9766
Kishan SharmaDivision of Neuroscience & Experimental Psychology, University of Manchester, Manchester, United Kingdom.
Terence StephensonUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-8871-7847
Trudie ChalderDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Natalia K RojasDivision of Surgery & Interventional Science, Faculty of Medical Sciences, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-6615-9618
Emma DalrympleUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-6645-932X
Kelsey McOwatImmunisation Department, Public Health England, London, United Kingdom.ORCID https://orcid.org/0000-0003-4170-1498
Ruth SimmonsImmunisation Department, Public Health England, London, United Kingdom.
Olivia SwannCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0001-7386-2849
CLoCk Consortium
Tamsin FordDepartment of Psychiatry, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-5295-4904
Roz ShafranUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-2729-4961

Funding

Medical Research Council MC_UU_00002/2
6 · The paper itself

Abstract

backgroundLittle is known about the long-term mental health consequences of the pandemic in children and young people (CYP), despite extremely high levels of exposure to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and the disruption to schooling and leisure activities due to the resultant restrictions. There are mixed findings from systematic reviews of how the pandemic affected CYP's mental health, which may be due to heterogeneous methods and poor quality studies. Most, but not all, suggest deterioration in mental health but population level studies may obscure the differing experiences of subgroups. The study questions are: (i) are there subgroups of CYP with distinct mental health profiles over the course of the second year of the Coronavirus Disease 2019 (COVID-19) pandemic (between April 2021 and May 2022); and (ii) do vulnerability factors influence CYP's mental health trajectories. METHODS AND

findingsA matched longitudinal cohort study of non-hospitalised test-positive and test-negative 11- to 17-year-old CYP in England were recruited from the UK Health Security Agency having undergone PCR testing for COVID-19. They completed the Strengths and Difficulties Questionnaire (SDQ) at least twice over a 12-month follow-up period. Overall, 8,518 of 17,918 (47.5%) CYP who returned their first SDQ at 3 or 6 months post-testing were included in the analytical sample. Associations between age, sex, ethnicity, socioeconomic status (SES), and an educational health and care plan (EHCP, indicating special educational needs) on SDQ score trajectories were examined separately, after adjusting for PCR test result. Findings from multilevel mixed-effects linear regression model showed that on average mental health symptoms as measured by the total SDQ score increased over time (B = 0.11 (per month), 95% CI = 0.09 to 0.12, p < 0.001) although this increase was small and not clinically significant. However, associations with time varied by age, such that older participants reported greater deterioration in mental health over time (B = 0.12 (per month), 95% CI = 0.10 to 0.14 for 15 to 17y; 0.08 (95% CI = 0.06 to 0.10) for 11 to 14y; pinteraction = 0.002) and by sex, with greater deterioration in girls. Children with an EHCP experienced less deterioration in their mental health compared to those without an EHCP. There was no evidence of differences in rate of change in total SDQ by ethnicity, SES, or physical health. Those with worse prior mental health did not appear to be disproportionately negatively affected over time. There are several limitations of the methodology including relatively low response rates in CLoCk and potential for recall bias.

conclusionsOverall, there was a statistically but not clinically significant decline in mental health during the pandemic. Sex, age, and EHCP status were important vulnerability factors that were associated with the rate of mental health decline, whereas ethnicity, SES, and prior poor physical health were not. The research highlights individual factors that could identify groups of CYP vulnerable to worsening mental health.

Indexed as

COVID-19AdolescentChildCohort StudiesCOVID-19 TestingFemaleHumansLongitudinal StudiesMental HealthPandemicsSARS-CoV-2

Identifiers

PMID38266043
PMCPMC10807843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.